Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Vale
VALE
$62.1B
| $86.9M | 0.13% |
6,651,236
+6,426,256
| +2,856% | +$83.1M |
|
177
Devon Energy
DVN
$54B
| $86.8M | 0.13% |
2,750,289
+1,898,951
| +223% | +$53.1M |
|
178
Lumen
LUMN
$6.13B
| $86.2M | 0.13% |
7,187,799
+1,424,823
| +25% | +$19.8M |
|
179
Chord Energy
CHRD
$8.09B
| $86.2M | 0.13% |
14,265,205
+91,060
| +0.6% | +$546K |
|
180
Boston Properties
BXP
$10.8B
| $86.1M | 0.13% |
643,006
+464,046
| +259% | +$59.6M |
|
181
MetLife
MET
$60B
| $85.3M | 0.13% |
2,004,675
+1,036,445
| +107% | +$45.8M |
|
182
SM Energy
SM
$8.85B
| $85.3M | 0.13% |
4,877,481
-3,735,950
| -43% | -$66.4M |
|
183
Motorola Solutions
MSI
$79.5B
| $85.3M | 0.13% |
607,290
+478,850
| +373% | +$62.1M |
|
184
Agilent Technologies
A
$44.9B
| $84.6M | 0.13% |
1,051,977
-579,804
| -36% | -$44M |
|
185
D.R. Horton
DHI
$41.5B
| $84.3M | 0.13% |
2,036,555
-1,236,157
| -38% | -$48.4M |
|
186
Axalta
AXTA
$7.75B
| $84.2M | 0.13% |
3,339,005
-1,849,934
| -36% | -$47.6M |
|
187
Vistra
VST
$45.7B
| $84.2M | 0.13% |
3,233,623
-168,468
| -5% | -$4.25M |
|
188
Costco
COST
$420B
| $84.1M | 0.13% |
347,216
+103,173
| +42% | +$22.6M |
|
189
ProPetro Holding
PUMP
$1.39B
| $83.8M | 0.13% |
3,719,366
+188,405
| +5% | +$3.37M |
|
|
RDS.A
190
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $83.8M | 0.13% |
1,338,272
+43,832
| +3% | +$2.71M |
|
191
Willis Towers Watson
WTW
$31.8B
| $83.6M | 0.13% |
476,114
+304,401
| +177% | +$50.5M |
|
192
Nomad Foods
NOMD
$1.65B
| $83.5M | 0.13% |
4,083,553
+3,689,054
| +935% | +$70.9M |
|
193
Allstate
ALL
$64.2B
| $82.1M | 0.12% |
872,038
-488,593
| -36% | -$44.2M |
|
|
USG
194
DELISTED
Usg
USG
| $81.6M | 0.12% |
1,883,493
-294,203
| -14% | -$12.7M |
|
|
ULTI
195
DELISTED
Ultimate Software Group Inc
ULTI
| $81.2M | 0.12% |
246,086
+104,989
| +74% | +$32.2M |
|
196
Ashland
ASH
$3.33B
| $80.5M | 0.12% |
1,030,271
+565,665
| +122% | +$43.6M |
|
197
Intuit
INTU
$100B
| $79.7M | 0.12% |
304,991
+80,788
| +36% | +$18.7M |
|
198
Eli Lilly
LLY
$1.12T
| $79.7M | 0.12% |
614,230
-885,389
| -59% | -$108M |
|
199
Yum! Brands
YUM
$41.8B
| $79.5M | 0.12% |
796,538
+674,054
| +550% | +$63.8M |
|
200
DexCom
DXCM
$34.8B
| $79.2M | 0.12% |
2,660,504
-59,032
| -2% | -$2.07M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.